The Asia-Pacific dermal fillers market is expected to grow at a CAGR of 8.3% during the forecast period and is forecast to reach $1.5 billion in 2025 as compared to $845 million in 2018. Rising disposable income, high proportion of middle-aged people is one of the major factors for the growth of the market. The major countries which will contribute to the market are China, India, and Japan. China is the biggest market contributor to the dermal fillers market. There is a high growth opportunity in this market due to the rising disposable income and increasing awareness of the cosmetic procedures in developed and emerging economies in the region. Moreover, the market is growing at an alarming rate which leads to an increase in the number of dermatological consultations, dermatology clinics and the increasing demand for dermatologists in the region.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-dermal-fillers-market
The Asia-Pacific dermal fillers market can be segmented based on application, type, and end-users. Based on application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other application. Moreover, based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-users, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/asia-pacific-dermal-fillers-market
Key players operating in the Asia-Pacific dermal fillers market include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. These companies adopt various strategies such as partnership & collaborations, finding a new market or product innovations in their core competency in order to stay competitive in the market.
Market Segmentation
By Application
- Face-Lift
- Lip Treatment/Enhancement
- Facial Line Correction Treatment
- Others (Acne Scar Treatment)
By Type
- Collagen Fillers
- Ploy-L-Lactic Acid (PLLA)
- Hyaluronic Acid (HA)
- Calcium Hydroxylapatite (CaHA)
- Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA))
By End-User
- Dermatology Clinics
- Hospitals
Regional Analysis
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- Allergan PLC
- BIOHA Laboratories
- BioPlus Co., Ltd.
- Croma-Pharma GmbH
- Cynosure LLC
- Korman Laboratories Ltd.
- Galderma Laboratories, L.P.
- Huons Co. Ltd.
- Merz Pharmaceuticals GmbH
- Sculpt Luxury Dermal Fillers Ltd.
- Shanghai Bioha Technologies Co., Ltd.
- Sinclair Pharma Ltd.
- Teoxane SA
- Vivacy Laboratories
- Zhejiang Jingjia Medical Technology Co., Ltd.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
